FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to toxicology and occupational pathology, and concerns the reduction of the cytotoxic effect of crystalline silicon dioxide. To do this, persons belonging to the risk group of this action are injected with the drug “Lymphomyozot”, 15 drops in 100 ml of water 3 times a day for 14 days, 4 times a year.
EFFECT: method provides effective prevention of the cytotoxic effect of crystalline silicon dioxide due to the ability of the drug to increase the resistance of macrophages to the action of dust particles and, accordingly, to provide a more effective alveolar clearance.
1 cl, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING BODY RESISTANCE TO HARMFUL ACTION OF AMORPHOUS SILICON DIOXIDE NANOPARTICLES | 2020 |
|
RU2738565C1 |
| METHOD FOR INCREASING RESISTANCE OF THE HUMAN BODY TO THE COMBINED CYTOTOXIC EFFECT OF SELENIUM AND COPPER OXIDE NANOPARTICLES | 2022 |
|
RU2786819C1 |
| METHOD OF MODELLING THE ESTIMATION OF COMBINATION TOXIC ACTION OF LOW-SOLUBLE DUSTS | 0 |
|
SU1569709A1 |
| METHOD FOR CALCULATING DEGREE OF ALVEOLAR MACROPHAGE SURFACE DAMAGE FROM ALUMINUM OXIDE PARTICLES | 2018 |
|
RU2693470C1 |
| REMEDIES FOR PROPHYLAXIS OF MALIGNANT NEOPLASMS | 1993 |
|
RU2031654C1 |
| METHOD FOR INCREASING BODY RESISTANCE TO GENERAL TOXIC AND GENOTOXIC ACTION OF A COMBINATION OF ALUMINUM, TITANIUM AND SILICON OXIDE NANOPARTICLES | 2018 |
|
RU2694844C1 |
| METHOD FOR INCREASING BODY RESISTANCE TO COMBINED HARMFUL EFFECT OF LEAD AND CADMIUM | 2019 |
|
RU2712954C1 |
| METHOD FOR INCREASE OF ORGANISM RESISTANCE TO COMBINED TOXIC ACTION OF NANOPARTICLES OF COPPER, ZINC AND LEAD OXIDES | 2017 |
|
RU2642674C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY ACTION | 2022 |
|
RU2801579C1 |
| METHOD OF PREDICTING DEVELOPMENT OF DIFFUSE ENDOBRONCHITIS IN EARLY AND ACUTE PERIODS OF CERVICAL-SPINAL TRAUMA | 2009 |
|
RU2398229C1 |
